BioCentury | Jan 20, 2014
Analyst Picks & Changes

Analyst picks & changes

...accelerate development of Alnylam's extra-hepatic short interfering RNA (siRNA) delivery programs. Amarin Corp. plc (NASDAQ:AMRN) MKM Partners...
BioCentury | Dec 24, 2012
Company News

MKM Partners LLC, M.M. Dillon & Co. other news

...Trading firm MKM Partners partnered with M.M. Dillon to form a combined venture - MKM Dillon...
...investment banking capabilities with MKM Partners' distribution platform. The companies could not be reached for details. MKM Partners...
BioCentury | Jun 20, 2011
Finance

Analyst tracks

...Analyst tracks Jon LeCroy joined MKM Partners as a managing director in equity research covering biotechnology and...
Items per page:
1 - 3 of 3
BioCentury | Jan 20, 2014
Analyst Picks & Changes

Analyst picks & changes

...accelerate development of Alnylam's extra-hepatic short interfering RNA (siRNA) delivery programs. Amarin Corp. plc (NASDAQ:AMRN) MKM Partners...
BioCentury | Dec 24, 2012
Company News

MKM Partners LLC, M.M. Dillon & Co. other news

...Trading firm MKM Partners partnered with M.M. Dillon to form a combined venture - MKM Dillon...
...investment banking capabilities with MKM Partners' distribution platform. The companies could not be reached for details. MKM Partners...
BioCentury | Jun 20, 2011
Finance

Analyst tracks

...Analyst tracks Jon LeCroy joined MKM Partners as a managing director in equity research covering biotechnology and...
Items per page:
1 - 3 of 3